nodes	percent_of_prediction	percent_of_DWPC	metapath
Ritodrine—PGD—Dacarbazine—melanoma	0.85	1	CbGbCtD
Ritodrine—GALR3—eye—melanoma	0.00829	0.247	CbGeAlD
Ritodrine—GALR3—retina—melanoma	0.00822	0.245	CbGeAlD
Ritodrine—GALR3—head—melanoma	0.00471	0.14	CbGeAlD
Ritodrine—PGD—neck—melanoma	0.00279	0.083	CbGeAlD
Ritodrine—PGD—eye—melanoma	0.00207	0.0617	CbGeAlD
Ritodrine—PGD—retina—melanoma	0.00205	0.0612	CbGeAlD
Ritodrine—PGD—skin of body—melanoma	0.0018	0.0537	CbGeAlD
Ritodrine—PGD—mammalian vulva—melanoma	0.00164	0.049	CbGeAlD
Ritodrine—PGD—head—melanoma	0.00118	0.035	CbGeAlD
Ritodrine—PGD—lymph node—melanoma	0.000824	0.0245	CbGeAlD
Ritodrine—Bezafibrate—PPARG—melanoma	0.000179	0.674	CrCbGaD
Ritodrine—Diethylstilbestrol—ABCB1—melanoma	8.64e-05	0.325	CrCbGaD
Ritodrine—GALR3—Signaling by GPCR—CXCL8—melanoma	6.99e-05	0.000606	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—CCR7—melanoma	6.98e-05	0.000605	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—GRM1—melanoma	6.98e-05	0.000605	CbGpPWpGaD
Ritodrine—PGD—Disease—HIF1A—melanoma	6.97e-05	0.000604	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—KISS1—melanoma	6.93e-05	0.0006	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—CXCR1—melanoma	6.71e-05	0.000582	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—IL2—melanoma	6.68e-05	0.000579	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—TERT—melanoma	6.66e-05	0.000577	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—RAC1—melanoma	6.64e-05	0.000575	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—MC1R—melanoma	6.61e-05	0.000573	CbGpPWpGaD
Ritodrine—PGD—Metabolism—PRKCA—melanoma	6.57e-05	0.000569	CbGpPWpGaD
Ritodrine—PGD—Metabolism—ERCC2—melanoma	6.51e-05	0.000564	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—HIF1A—melanoma	6.37e-05	0.000552	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—RHOB—melanoma	6.35e-05	0.00055	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—CCR7—melanoma	6.34e-05	0.000549	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—GRM1—melanoma	6.34e-05	0.000549	CbGpPWpGaD
Ritodrine—PGD—Disease—NOS2—melanoma	6.34e-05	0.000549	CbGpPWpGaD
Ritodrine—PGD—Disease—NOTCH1—melanoma	6.28e-05	0.000544	CbGpPWpGaD
Ritodrine—PGD—Disease—CD80—melanoma	6.15e-05	0.000533	CbGpPWpGaD
Ritodrine—PGD—Disease—KIT—melanoma	6.14e-05	0.000532	CbGpPWpGaD
Ritodrine—PGD—Disease—APC—melanoma	6.14e-05	0.000532	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—KDR—melanoma	6.09e-05	0.000527	CbGpPWpGaD
Ritodrine—PGD—Disease—EGF—melanoma	6.07e-05	0.000526	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—FN1—melanoma	5.86e-05	0.000508	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—CXCR2—melanoma	5.79e-05	0.000501	CbGpPWpGaD
Ritodrine—PGD—Disease—BRAF—melanoma	5.77e-05	0.0005	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—RHOB—melanoma	5.77e-05	0.0005	CbGpPWpGaD
Ritodrine—ADRB2—GPCR ligand binding—EDN1—melanoma	5.74e-05	0.000497	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—NOTCH1—melanoma	5.74e-05	0.000497	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—RAC2—melanoma	5.69e-05	0.000493	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—CD80—melanoma	5.62e-05	0.000487	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—PIK3CG—melanoma	5.61e-05	0.000486	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—APC—melanoma	5.61e-05	0.000486	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—KIT—melanoma	5.61e-05	0.000486	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—NRAS—melanoma	5.61e-05	0.000486	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—EGF—melanoma	5.55e-05	0.00048	CbGpPWpGaD
Ritodrine—PGD—Disease—MAP2K1—melanoma	5.43e-05	0.000471	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PLCB4—melanoma	5.4e-05	0.000468	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—CXCL1—melanoma	5.4e-05	0.000468	CbGpPWpGaD
Ritodrine—PGD—Disease—PIK3CD—melanoma	5.4e-05	0.000468	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—MAPK3—melanoma	5.37e-05	0.000465	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—BRAF—melanoma	5.27e-05	0.000457	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—CXCR2—melanoma	5.25e-05	0.000455	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—RAC2—melanoma	5.17e-05	0.000448	CbGpPWpGaD
Ritodrine—PGD—Disease—FGF2—melanoma	5.17e-05	0.000448	CbGpPWpGaD
Ritodrine—PGD—Metabolism—PIK3CG—melanoma	5.14e-05	0.000445	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—IGF1—melanoma	5.14e-05	0.000445	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—MAPK1—melanoma	5.11e-05	0.000443	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—EGFR—melanoma	5.11e-05	0.000443	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—WNT5A—melanoma	5.09e-05	0.000441	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—CUL3—melanoma	5.08e-05	0.00044	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—TRRAP—melanoma	5.08e-05	0.00044	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—MAP2K1—melanoma	4.96e-05	0.00043	CbGpPWpGaD
Ritodrine—PGD—Metabolism—PPARG—melanoma	4.96e-05	0.00043	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—AKR1B10—melanoma	4.94e-05	0.000428	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—PIK3CD—melanoma	4.93e-05	0.000427	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—F2R—melanoma	4.92e-05	0.000426	CbGpPWpGaD
Ritodrine—GALR3—GPCR downstream signaling—PIK3CA—melanoma	4.89e-05	0.000423	CbGpPWpGaD
Ritodrine—PGD—Disease—MDM2—melanoma	4.84e-05	0.000419	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—KRAS—melanoma	4.83e-05	0.000418	CbGpPWpGaD
Ritodrine—PGD—Disease—ERBB2—melanoma	4.77e-05	0.000413	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—EDNRB—melanoma	4.76e-05	0.000413	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—FGF2—melanoma	4.72e-05	0.000409	CbGpPWpGaD
Ritodrine—PGD—Disease—PIK3CB—melanoma	4.71e-05	0.000408	CbGpPWpGaD
Ritodrine—PGD—Disease—CD4—melanoma	4.7e-05	0.000407	CbGpPWpGaD
Ritodrine—PGD—Disease—PTGS2—melanoma	4.66e-05	0.000404	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—F2RL1—melanoma	4.6e-05	0.000398	CbGpPWpGaD
Ritodrine—PGD—Metabolism—PIK3CD—melanoma	4.52e-05	0.000392	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—GNA11—melanoma	4.5e-05	0.00039	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—GAB2—melanoma	4.5e-05	0.00039	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—F2R—melanoma	4.47e-05	0.000387	CbGpPWpGaD
Ritodrine—PGD—Metabolism—ALB—melanoma	4.46e-05	0.000387	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—PIK3CA—melanoma	4.44e-05	0.000384	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—MDM2—melanoma	4.42e-05	0.000383	CbGpPWpGaD
Ritodrine—PGD—Disease—CDKN1B—melanoma	4.42e-05	0.000382	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—ERBB2—melanoma	4.36e-05	0.000377	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—EDNRB—melanoma	4.33e-05	0.000375	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—GRM3—melanoma	4.32e-05	0.000374	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—PIK3CB—melanoma	4.3e-05	0.000372	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—CXCR4—melanoma	4.23e-05	0.000366	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—GNAQ—melanoma	4.18e-05	0.000362	CbGpPWpGaD
Ritodrine—PGD—Disease—CTNNB1—melanoma	4.17e-05	0.000361	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—CXCL8—melanoma	4.13e-05	0.000358	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—HRAS—melanoma	4.1e-05	0.000355	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—KISS1—melanoma	4.1e-05	0.000355	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—GNA11—melanoma	4.09e-05	0.000354	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—GAB2—melanoma	4.09e-05	0.000354	CbGpPWpGaD
Ritodrine—PGD—Disease—CDKN1A—melanoma	4.07e-05	0.000353	CbGpPWpGaD
Ritodrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—melanoma	4.07e-05	0.000353	CbGpPWpGaD
Ritodrine—PGD—Disease—PTEN—melanoma	4.07e-05	0.000352	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—CDKN1B—melanoma	4.03e-05	0.000349	CbGpPWpGaD
Ritodrine—GALR3—GPCR downstream signaling—AKT1—melanoma	3.99e-05	0.000346	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—CXCR1—melanoma	3.97e-05	0.000344	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—SKI—melanoma	3.97e-05	0.000344	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—CASP3—melanoma	3.95e-05	0.000342	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—IL2—melanoma	3.95e-05	0.000342	CbGpPWpGaD
Ritodrine—PGD—Metabolism—PIK3CB—melanoma	3.94e-05	0.000341	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—IL6—melanoma	3.93e-05	0.00034	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—MC1R—melanoma	3.91e-05	0.000338	CbGpPWpGaD
Ritodrine—PGD—Metabolism—PTGS2—melanoma	3.9e-05	0.000338	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—AKT3—melanoma	3.86e-05	0.000334	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—CCND1—melanoma	3.85e-05	0.000333	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—CXCR4—melanoma	3.84e-05	0.000333	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—CTNNB1—melanoma	3.81e-05	0.00033	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—GNAQ—melanoma	3.8e-05	0.000329	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—GRM1—melanoma	3.75e-05	0.000324	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—CCR7—melanoma	3.75e-05	0.000324	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—MMP9—melanoma	3.74e-05	0.000324	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—CDKN1A—melanoma	3.72e-05	0.000322	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—PTEN—melanoma	3.71e-05	0.000322	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—NFKB1—melanoma	3.7e-05	0.00032	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—SUFU—melanoma	3.65e-05	0.000316	CbGpPWpGaD
Ritodrine—PGD—Disease—STAT3—melanoma	3.64e-05	0.000315	CbGpPWpGaD
Ritodrine—PGD—Disease—NRAS—melanoma	3.63e-05	0.000314	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—AKT1—melanoma	3.62e-05	0.000314	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—AKT3—melanoma	3.51e-05	0.000304	CbGpPWpGaD
Ritodrine—PGD—Disease—MAPK3—melanoma	3.47e-05	0.000301	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—RHOB—melanoma	3.41e-05	0.000295	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—BCL2L11—melanoma	3.41e-05	0.000295	CbGpPWpGaD
Ritodrine—PGD—Metabolism—PTEN—melanoma	3.4e-05	0.000295	CbGpPWpGaD
Ritodrine—PGD—Disease—MYC—melanoma	3.38e-05	0.000293	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—VEGFA—melanoma	3.36e-05	0.000291	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—STAT3—melanoma	3.32e-05	0.000288	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—NRAS—melanoma	3.31e-05	0.000287	CbGpPWpGaD
Ritodrine—PGD—Disease—MAPK1—melanoma	3.31e-05	0.000286	CbGpPWpGaD
Ritodrine—PGD—Disease—EGFR—melanoma	3.3e-05	0.000286	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—HDAC6—melanoma	3.27e-05	0.000284	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—EDN1—melanoma	3.24e-05	0.000281	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—MAPK3—melanoma	3.17e-05	0.000275	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—CSF2—melanoma	3.17e-05	0.000275	CbGpPWpGaD
Ritodrine—PGD—Disease—KRAS—melanoma	3.12e-05	0.00027	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—CXCR2—melanoma	3.1e-05	0.000269	CbGpPWpGaD
Ritodrine—ADRB2—GPCR ligand binding—CXCL8—melanoma	3.1e-05	0.000269	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—MYC—melanoma	3.09e-05	0.000267	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—RAC2—melanoma	3.05e-05	0.000264	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—PRKCA—melanoma	3.04e-05	0.000263	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—MAPK1—melanoma	3.02e-05	0.000262	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—EGFR—melanoma	3.02e-05	0.000262	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—VEGFC—melanoma	3.01e-05	0.00026	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—WNT5A—melanoma	3.01e-05	0.00026	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—EDN1—melanoma	2.95e-05	0.000255	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—CSF2—melanoma	2.88e-05	0.000249	CbGpPWpGaD
Ritodrine—PGD—Disease—PIK3CA—melanoma	2.87e-05	0.000248	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—KRAS—melanoma	2.85e-05	0.000247	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—RAC1—melanoma	2.82e-05	0.000244	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—PRKCA—melanoma	2.76e-05	0.000239	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—MAP2K2—melanoma	2.7e-05	0.000234	CbGpPWpGaD
Ritodrine—PGD—Disease—HRAS—melanoma	2.65e-05	0.00023	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—F2R—melanoma	2.64e-05	0.000229	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—PIK3CA—melanoma	2.62e-05	0.000227	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—RAC1—melanoma	2.56e-05	0.000222	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—EDNRB—melanoma	2.56e-05	0.000221	CbGpPWpGaD
Ritodrine—PGD—Disease—IL6—melanoma	2.54e-05	0.00022	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—TP53—melanoma	2.54e-05	0.00022	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PTK2B—melanoma	2.48e-05	0.000215	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—HRAS—melanoma	2.42e-05	0.00021	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—GNA11—melanoma	2.41e-05	0.000209	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—GAB2—melanoma	2.41e-05	0.000209	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—FLT1—melanoma	2.4e-05	0.000208	CbGpPWpGaD
Ritodrine—PGD—Metabolism—PIK3CA—melanoma	2.4e-05	0.000208	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—PIK3CG—melanoma	2.38e-05	0.000206	CbGpPWpGaD
Ritodrine—PGD—Disease—AKT1—melanoma	2.34e-05	0.000203	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—IL6—melanoma	2.32e-05	0.000201	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—FOXO4—melanoma	2.27e-05	0.000197	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—HDAC2—melanoma	2.27e-05	0.000197	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—CXCR4—melanoma	2.27e-05	0.000197	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—GNAQ—melanoma	2.24e-05	0.000194	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—PIK3CG—melanoma	2.16e-05	0.000187	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—AKT1—melanoma	2.14e-05	0.000185	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—SYK—melanoma	2.11e-05	0.000183	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—PIK3CD—melanoma	2.09e-05	0.000181	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—ITGAV—melanoma	2.07e-05	0.000179	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—AKT3—melanoma	2.07e-05	0.000179	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—NGFR—melanoma	2.07e-05	0.000179	CbGpPWpGaD
Ritodrine—PGD—Metabolism—AKT1—melanoma	1.96e-05	0.00017	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—SOCS1—melanoma	1.92e-05	0.000166	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—MAP2K1—melanoma	1.91e-05	0.000166	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—S100B—melanoma	1.91e-05	0.000166	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—PIK3CD—melanoma	1.9e-05	0.000165	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—ERBB4—melanoma	1.83e-05	0.000158	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—PIK3CB—melanoma	1.82e-05	0.000158	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—CDKN2B—melanoma	1.81e-05	0.000157	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—CD86—melanoma	1.75e-05	0.000152	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—CXCL8—melanoma	1.75e-05	0.000152	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—EDN1—melanoma	1.74e-05	0.000151	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—CSF2—melanoma	1.7e-05	0.000147	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—FGF1—melanoma	1.7e-05	0.000147	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—IL2—melanoma	1.68e-05	0.000145	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—E2F1—melanoma	1.66e-05	0.000144	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—PIK3CB—melanoma	1.66e-05	0.000143	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PDGFRA—melanoma	1.65e-05	0.000143	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—ITGB3—melanoma	1.63e-05	0.000141	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PRKCA—melanoma	1.63e-05	0.000141	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—SPP1—melanoma	1.6e-05	0.000138	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—MAP2K2—melanoma	1.59e-05	0.000138	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—CXCL8—melanoma	1.59e-05	0.000138	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—IL2—melanoma	1.52e-05	0.000132	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—TERT—melanoma	1.52e-05	0.000131	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—RAC1—melanoma	1.51e-05	0.000131	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—HIF1A—melanoma	1.45e-05	0.000126	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—KDR—melanoma	1.39e-05	0.00012	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—FN1—melanoma	1.33e-05	0.000116	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—NOTCH1—melanoma	1.31e-05	0.000113	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—CD80—melanoma	1.28e-05	0.000111	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PIK3CG—melanoma	1.28e-05	0.000111	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—APC—melanoma	1.28e-05	0.000111	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—KIT—melanoma	1.28e-05	0.000111	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—NRAS—melanoma	1.28e-05	0.000111	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—EGF—melanoma	1.26e-05	0.000109	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—MAPK3—melanoma	1.22e-05	0.000106	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—BRAF—melanoma	1.2e-05	0.000104	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—IGF1—melanoma	1.17e-05	0.000101	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—MAPK1—melanoma	1.16e-05	0.000101	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—EGFR—melanoma	1.16e-05	0.000101	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—MAP2K1—melanoma	1.13e-05	9.79e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PIK3CD—melanoma	1.12e-05	9.72e-05	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—PIK3CA—melanoma	1.11e-05	9.63e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—KRAS—melanoma	1.1e-05	9.52e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—FGF2—melanoma	1.07e-05	9.31e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—PIK3CA—melanoma	1.01e-05	8.75e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—MDM2—melanoma	1.01e-05	8.71e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—ERBB2—melanoma	9.92e-06	8.59e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PIK3CB—melanoma	9.79e-06	8.48e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—CXCL8—melanoma	9.4e-06	8.15e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—HRAS—melanoma	9.34e-06	8.09e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—CDKN1B—melanoma	9.18e-06	7.95e-05	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—AKT1—melanoma	9.08e-06	7.87e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—CASP3—melanoma	9e-06	7.8e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—IL2—melanoma	8.99e-06	7.78e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—IL6—melanoma	8.94e-06	7.75e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—CCND1—melanoma	8.76e-06	7.59e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—CTNNB1—melanoma	8.68e-06	7.51e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—MMP9—melanoma	8.51e-06	7.37e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—CDKN1A—melanoma	8.48e-06	7.34e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PTEN—melanoma	8.46e-06	7.32e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—NFKB1—melanoma	8.42e-06	7.29e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—AKT1—melanoma	8.25e-06	7.15e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—VEGFA—melanoma	7.64e-06	6.62e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—STAT3—melanoma	7.56e-06	6.55e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—NRAS—melanoma	7.54e-06	6.53e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—MAPK3—melanoma	7.23e-06	6.26e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—MYC—melanoma	7.03e-06	6.09e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—MAPK1—melanoma	6.87e-06	5.95e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—EGFR—melanoma	6.87e-06	5.95e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—KRAS—melanoma	6.49e-06	5.62e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PIK3CA—melanoma	5.97e-06	5.17e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—TP53—melanoma	5.77e-06	5e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—HRAS—melanoma	5.52e-06	4.78e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—IL6—melanoma	5.28e-06	4.58e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—AKT1—melanoma	4.87e-06	4.22e-05	CbGpPWpGaD
